Stock Details
4578.T is Otsuka Holdings Co., Ltd.'s stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 4,682.70๏ฟฅ. Average daily volumn in 3 months 1.01M. Market cap 2.42T



Stock symbol : 4578.T. Exchange : Tokyo. Currency : JPY
Lastest price : 4,470.00๏ฟฅ. Total volume : 1.15M. Market state PREPRE
Click reload if you want to check the lastest price on market!!!

Otsuka Holdings Co., Ltd. (4578.T)
Last Price
4,470.00๏ฟฅ
Change
-22.00
Volume
1.15M

Previous Close4,492.00
Open4,457.00
Day Range4,410.00-4,475.00
Bid0.00 x N/A
Ask0.00 x N/A
Volume1.15M
Average Volume1.01M
Market Cap2.42T
Beta0.35
52 Week Range3,831.00-5,000.00
Trailing P/E23.36
Foward P/E15.09
Dividend (Yield %)2.24%
Ex-Dividend Date2022-12-29



Financial Details


According to Otsuka Holdings Co., Ltd.'s financial reports the company's revenue in 2021 were 1.5T an increase(0%) over the years 2020 revenue that were of 1.42T. In 2021 the company's total earnings were 125.46B while total earnings in 2020 were 148.14B(-15.54%).


Loading ...



Organization

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTร‰ Jelly, a conditioning food product; BODYMAINTร‰ Drink, a drinkable-liquid; POCA... RI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.

Market Cap:
2.42T
Revenue:
1.5T
Total Assets:
2.82T
Total Cash:
410.68B


News about "Otsuka Holdings Co., Ltd."

Otsuka Holdings Co., Ltd. (4578.T)

Source from : Yahoo Finance - 2 days ago

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...See details»


otsuka-medical-devices-announces-results-of-radiance-ii-pivotal-trial-at-tct-2022-annual-meeting-image

Otsuka Medical Devices Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting

Source from : Yahoo - 6 days ago

Otsuka Medical Devices Co., Ltd. ("Otsuka Medical Devices") a wholly owned subsidiary of Otsuka Holdings today announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating ...See details»


Leukemia Therapeutics Global Market Report 2022: A $20+ Billion Market in 2026 - Long-term Forecast to 2031 - ResearchAndMarkets.com

Source from : PharmiWeb - 13 days ago

The "Leukemia Therapeutics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.Major players in the leukemia therapeutics market are Novartis International AG, AbbVie ...See details»


ReCor Medical to Present RADIANCE II US Pivotal Trial Data in Late-Breaking Presentation at TCT Conference

Source from : MarketWatch - 11 days ago

ReCor Medical, Inc. ("ReCor"), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., today announced late-breaking data from its RADIANCE II U.S. FDA IDE pivotal trial will be presented at ...See details»


Otsuka announces EC approval of Lupkynisยฎ (voclosporin) as first oral treatment for active lupus nephritis

Source from : PharmiWeb - 5 days ago

Otsuka Pharmaceutical Europe Ltd. today announces that the European Commission (EC) has approved Lupkynisยฎ (voclosporin) in combination with mycophenolate mofetil for the treatment of adult patients ...See details»


north-america-smart-pills-market-report-2022-featuring-capso-vision-medtronic-check-cap-pentax-medical-olympus-otsuka-holdings-image

North America Smart Pills Market Report 2022: Featuring Capso Vision, Medtronic, Check-Cap, PENTAX Medical, Olympus & Otsuka Holdings

Source from : Yahoo Canada Sports - 5 days ago

The "North America Smart Pills Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application, Disease Indication, and End User" report has been added to ResearchAndMarkets.com's ...See details»


Vitamin Supplements Market Size, Trends, Share, Growth, Key Players Analysis, Emerging Opportunities and Potential of Industry from 2022-2029

Source from : MarketWatch - 5 days ago

Vitamin Supplements Market 2022 Global Industry Research report 2022 covers a detailed study of the Vitamin Supplements Market size, growth, and share, trends, consumption, segmen ...See details»


Otsuka Holdings Co Ltd

Source from : Reuters - 12 days ago

Otsuka Holdings Co., Ltd. is a Japan-based company mainly engaged in the medical and nutraceuticals related business and other businesses. The Company operates through four business segments.See details»


Otsuka Holdings Ltd (4578)

Source from : Investing - 21 days ago

View advanced dividend insights and history for in-depth analysis of historical dividend payouts and performance.See details»


Otsuka Holdings Co. Ltd.

Source from : Barron's - 11 month ago

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...See details»


Otsuka Holdings Ltd (4578)

Source from : Investing - 3 days ago

Investing.com โ€“ Japan equities were higher at the close on Monday, as gains in the Power, Transportation Equipment and Precision Instruments sectors propelled shares higher. At... Otsuka Holdings Co., ...See details»


Otsuka Holdings Co. Ltd.

Source from : Wall Street Journal - 4 days ago

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...See details»


Otsuka Holdings Co., Ltd. (OTSKF)

Source from : Yahoo Finance - 10 days ago

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...See details»


OTSKY Otsuka Holdings Co., Ltd.

Source from : Seeking Alpha - 11 days ago

To ensure this doesnโ€™t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our ...See details»